Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.

MLA

Yousef, Abdelrahman, et al. “Impact of KRAS Mutations and Co-Mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.” Research Square, Aug. 2023. EBSCOhost, https://doi.org/10.21203/rs.3.rs-3195257/v1.

APA

Yousef, A., Yousef, M., Chowdhury, S., Abdilleh, K., Knafl, M., Edelkamp, P., Alfaro-Munoz, K., Chacko, R., Peterson, J., Smaglo, B. G., Wolff, R. A., Pant, S., Lee, M. S., Willis, J., Overman, M., Doss, S., Matrisian, L., Hurd, M. W., Snyder, R., … Zhao, D. (2023). Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma. Research Square. https://doi.org/10.21203/rs.3.rs-3195257/v1

Chicago

Yousef, Abdelrahman, Mahmoud Yousef, Saikat Chowdhury, Kawther Abdilleh, Mark Knafl, Paul Edelkamp, Kristin Alfaro-Munoz, et al. 2023. “Impact of KRAS Mutations and Co-Mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.” Research Square, August. doi:10.21203/rs.3.rs-3195257/v1.